Categories: Prescription Medication
Description:
Enzalutamide is a potent androgen receptor inhibitor used in combination with androgen deprivation therapy (ADT) for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC). It blocks androgen signaling more completely than ADT alone by preventing testosterone from binding to prostate cancer cells.
Clinical trials (e.g., ARCHES, ENZAMET) have shown that enzalutamide significantly improves overall survival and delays disease progression in men with both low- and high-volume metastatic disease. It is taken as a once-daily oral pill and is often chosen for patients who want to avoid chemotherapy. Common side effects include fatigue, hypertension, falls, and cognitive effects, so patient selection and monitoring are important.
Treatment For:
AI generated Summary: Based on the provided information, there are no reviews or ratings available for the treatment 'Enzalutamide' against the disease 'Prostate Cancer, Metastatic hormone-sensitive prostate cancer'. Without any reviews or ratings, it is not possible to determine the effectiveness of this treatment for the specified condition.
The information, including but not limited to, text, graphics, images and other material contained on this website/app are for informational purposes only. No material on this site/app is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website/app.
Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.
